ArticleFrontiers in neurology
Clinical features, etiological spectrum, and outcomes of neurological patients initially presenting with psychiatric symptoms.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Neurological disorders can manifest with psychiatric symptoms as the initial presentation (PSIP), leading to diagnostic challenges and delayed treatment. Data on this patient population remain limited. Methods: We conducted a retrospective cohort study of patients admitted to a tertiary neurology department between 2019 and 2023 with PSIP. A structured screening protocol using predefined behavioral keywords was applied, followed by independent case review by two neurologists and a psychiatrist to confirm eligibility. Final diagnoses were adjudicated by consensus using contemporary diagnostic criteria. Poor outcome was defined as modified Rankin Scale score >2 at discharge. Multivariable logistic regression was used to identify independent predictors of poor outcome, and a risk score was developed based on these factors. Results: Of 16,473 screened admissions, 76 patients (mean age 55.8 ± 18.2 years; 42.1% female) met inclusion criteria. Most patients presented with acute-onset (92.1%) non-specific behavioral disturbance (63.2%), and nearly one-third (31.6%) had isolated psychiatric symptoms without any accompanying neurological signs. The leading etiologies were CNS infections (55.3%), predominantly viral encephalitis (40.8%), followed by cerebrovascular diseases (14.5%) and autoimmune encephalitis (13.2%). Poor outcome occurred in 32 patients (42.1%). Independent predictors of poor outcome were hyponatremia on admission (OR, 3.9; 95% CI, 1.3-11.8), viral encephalitis etiology (OR, 3.1; 95% CI, 1.1-8.7), and ICU admission (OR, 4.8; 95% CI, 1.3-17.6). A risk score combining these three factors effectively stratified patients (AUC 0.88; 95% CI, 0.80-0.96), with poor outcome rates ranging from 7.1% (score 0) to 100% (score 3). Subgroup analyses revealed that among viral encephalitis patients, those with PSIP had significantly higher rates of hyponatremia (41.9% vs. 15.2%, Conclusion: PSIP represents a critical clinical situation in which underlying neurological disorders, particularly viral encephalitis and autoimmune encephalitis are common. Hyponatremia serves as a readily available diagnostic clue and independent predictor of poor prognosis. The absence of neurological signs does not exclude serious underlying pathology. However, these findings are derived from a single tertiary center with a modest sample size and require validation in broader populations. Early comprehensive evaluation, including CSF analysis and neuroimaging, is essential to improve outcomes in this diagnostically challenging population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.